US Stock MarketDetailed Quotes

CKPT Checkpoint Therapeutics

Watchlist
  • 1.830
  • +0.040+2.23%
Close May 29 16:00 ET
  • 1.770
  • -0.060-3.28%
Post 19:21 ET
67.44MMarket Cap-701P/E (TTM)

About Checkpoint Therapeutics Company

Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio includes CK-301, CK-101, CK-103, CK-302, and Anti-CAIX. The company was founded on November 10, 2014 and is headquartered in Waltham, MA.

Company Profile

SymbolCKPT
Company NameCheckpoint Therapeutics
Listing DateJun 26, 2017
Founded2014
CEOMr. James F. Oliviero, III
MarketNASDAQ
Employees23
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address95 Sawyer Road,Suite 110
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02453
Phone1-781-652-4500

Company Executives

  • Name
  • Position
  • Salary
  • James F. Oliviero, III
  • Director, President and Chief Executive Officer
  • 1.64M
  • Garrett Gray
  • Chief Financial Officer, Corporate Secretary and Treasurer
  • 712.88K
  • Michael S. Weiss
  • Chairman of the Board
  • 110.00K
  • Dr. Lindsay A. Rosenwald, M.D.
  • Director
  • 100.00K
  • Dr. Amit Sharma, F.A.C.P.
  • Independent Director
  • --
  • Neil Herskowitz
  • Independent Director
  • 110.00K
  • Christian Bechon
  • Independent Director
  • 100.00K
  • Barry Salzman
  • Independent Director
  • 100.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg